
Sign up to save your podcasts
Or


Rheumatologist Dr. Marina Magrey discusses her latest research on biologic DMARD dose tapering in axial spondyloarthritis, outlining when it may be appropriate, its risks and benefits, and key considerations for patients.
By The Spondylitis Association of America (SAA)4.8
3131 ratings
Rheumatologist Dr. Marina Magrey discusses her latest research on biologic DMARD dose tapering in axial spondyloarthritis, outlining when it may be appropriate, its risks and benefits, and key considerations for patients.

91,129 Listeners

38,937 Listeners

5,101 Listeners

87,779 Listeners

112,741 Listeners

56,533 Listeners

14,956 Listeners

9,277 Listeners

8,896 Listeners

57,890 Listeners

29,203 Listeners

16,120 Listeners

41,570 Listeners

10,818 Listeners

1,190 Listeners